Matt Larew
Stock Analyst at William Blair
(0.04)
# 3,320
Out of 4,479 analysts
11
Total ratings
14.29%
Success rate
-32.99%
Average return
Main Sectors:
8 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMED Amedisys | Downgrades: Market Perform | n/a | $96.74 | - | 1 | Jul 1, 2024 | |
| DNA Ginkgo Bioworks Holdings | Downgrades: Underperform | n/a | $0.35 | - | 3 | May 10, 2024 | |
| ATR AptarGroup | Upgrades: Outperform | n/a | $140.40 | - | 1 | Apr 29, 2024 | |
| TECH Bio-Techne | Initiates: Outperform | n/a | $71.24 | - | 1 | Aug 28, 2023 | |
| AVTR Avantor | Downgrades: Market Perform | n/a | $20.58 | - | 1 | Jul 31, 2023 | |
| INNV InnovAge Holding | Downgrades: Market Perform | n/a | $5.03 | - | 2 | Sep 22, 2021 | |
| MXCT MaxCyte | Initiates: Outperform | n/a | $3.72 | - | 1 | Aug 24, 2021 | |
| TWST Twist Bioscience | Initiates: Outperform | n/a | $47.32 | - | 1 | Jun 29, 2021 |
Amedisys
Jul 1, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $96.74
Upside: -
Ginkgo Bioworks Holdings
May 10, 2024
Downgrades: Underperform
Price Target: n/a
Current: $0.35
Upside: -
AptarGroup
Apr 29, 2024
Upgrades: Outperform
Price Target: n/a
Current: $140.40
Upside: -
Bio-Techne
Aug 28, 2023
Initiates: Outperform
Price Target: n/a
Current: $71.24
Upside: -
Avantor
Jul 31, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $20.58
Upside: -
InnovAge Holding
Sep 22, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $5.03
Upside: -
MaxCyte
Aug 24, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.72
Upside: -
Twist Bioscience
Jun 29, 2021
Initiates: Outperform
Price Target: n/a
Current: $47.32
Upside: -